Expression of SGLT1 and SGLT2 in Breast Cancer and Potential Anticancer Effects of SGLT1 Inhibitors

被引：0

作者：

Tsunokake, Satoko ^{[1
]}

Iwabichi, Erina ^{[2
]}

Miki, Yasuhiro ^{[3
]}

Kanai, Ayako ^{[4
]}

Onodera, Yoshiaki ^{[3
]}

Ishida, Takanori ^{[1
]}

Sasano, Hironobu ^{[3
]}

Suzuki, Takashi ^{[2
,3
,5
]}

机构：

[1] Tohoku Univ, Dept Breast & Endocrine Surg Oncol, Sendai, Miyagi, Japan

[2] Tohoku Univ, Dept Pathol & Histotechnol, Sendai, Miyagi, Japan

[3] Tohoku Univ, Dept Anat Pathol, Sendai, Miyagi, Japan

[4] Hachinohe Municipal Hosp, Dept Breast Surg, Hachinohe, Aomori, Japan

[5] Tohoku Univ Hosp, Dept Pathol, Sendai, Miyagi, Japan

来源：

CANCER SCIENCE | 2024年 / 115卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-3266

引用

页码：1939 / 1939

页数：1

共 50 条

[21] An update of SGLT1 and SGLT2 inhibitors in early phase diabetes-type 2 clinical trials [J].

Adeghate, Ernest ;

Mohsin, Sahar ;

Adi, Faisal ;

Ahmed, Fares ;

Yahya, Ali ;

Kalasz, Huba ;

Tekes, Kornelia ;

Adeghate, Ernest A. .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (09) :811-820

[22] Dual SGLT1 and SGLT2 inhibition: more than the sum of its parts [J].

Sanchez-Munoz, Enrique ;

Requena-Ibanez, Juan Antonio ;

Badimon, Juan Jose .

REVISTA ESPANOLA DE CARDIOLOGIA, 2024, 77 (07) :510-514

[23] Localizations of Na+-d-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart [J].

Ivana Vrhovac ;

Daniela Balen Eror ;

Dirk Klessen ;

Christa Burger ;

Davorka Breljak ;

Ognjen Kraus ;

Nikola Radović ;

Stipe Jadrijević ;

Ivan Aleksic ;

Thorsten Walles ;

Christoph Sauvant ;

Ivan Sabolić ;

Hermann Koepsell .

Pflügers Archiv - European Journal of Physiology, 2015, 467 :1881-1898

[24] Molecular docking and dynamics simulation of Orthosiphon stamineus against SGLT1 and SGLT2 [J].

Subbiah, Usha ;

Ajith, Athira ;

Subbiah, Harini Venkata .

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (23) :13663-13678

[25] The Na+-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer [J].

Koepsell, Hermann .

PHARMACOLOGY & THERAPEUTICS, 2017, 170 :148-165

[26] Localizations of Na+-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart [J].

Vrhovac, Ivana ;

Eror, Daniela Balen ;

Klessen, Dirk ;

Burger, Christa ;

Breljak, Davorka ;

Kraus, Ognjen ;

Radovic, Nikola ;

Jadrijevic, Stipe ;

Aleksic, Ivan ;

Walles, Thorsten ;

Sauvant, Christoph ;

Sabolic, Ivan ;

Koepsell, Hermann .

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2015, 467 (09) :1881-1898

[27] Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2 [J].

Chiara Ghezzi ;

Donald D. F. Loo ;

Ernest M. Wright .

Diabetologia, 2018, 61 :2087-2097

[28] Does SGLT1 Inhibition Add Benefit to SGLT2 Inhibition in Type 2 Diabetes? [J].

Pitt, Bertram ;

Bhatt, Deepak L. .

CIRCULATION, 2021, 144 (01) :4-6

[29] Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2 [J].

Ghezzi, Chiara ;

Loo, Donald D. F. ;

Wright, Ernest M. .

DIABETOLOGIA, 2018, 61 (10) :2087-2097

[30] SGLT1 does compensate for SGLT2 inhibition (vol 2, pg 256, 2016) [J].

de Leeuw .

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2018, 4 (02) :101-101

← 1 2 3 4 5 →